Amniotic-derived products, including amniotic membrane and amniotic fluid products, are one subtype of orthobiologic that are considered a potential treatment option for augmentation of joint inflammation and healing. An amniotic membrane or amnion is a thin membrane forming a closed sac around the embryos or fetuses, and mammals and containing the amniotic fluid. The most common types of amniotic membranes used are cryopreserved amniotic membranes and lyophilized amniotic membranes.
Get Free PDF Research Report : https://meditechinsights.com/amniotic-products-market/request-sample/
Adoption of Amniotic Based Products in Wound Healing
Amniotic membranes are made of structural collagen and extracellular matrix, regenerative, and biologically active cells, all of which interact with one another to regulate the healing processes. In the complex cascade of wound healing, a hallmark of a chronic non-healing wound is prolonged inflammation. This disrupts the healing cycle, leading to a decrease in normal proliferation of growth factors as well as an imbalance in protective versus degradative enzymes favoring destruction of the extracellular matrix. Amniotic membrane can help facilitate wound healing by providing the key growth factors and other healing cascades that adhere to the extracellular matrix to enhance tissue growth and healing.
Rising Potential of Amniotic Membrane Products in Regenerative Medicines
Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering, and the production of artificial organs. The amniotic membrane (Amnio-M) finds multiple applications in regenerative medicine. It acts as a highly biocompatible natural scaffold and as a source of several types of stem cells and potent growth factors. The Amnio-M possess unique characteristics that render them useful in diverse applications such as the tracheal reconstruction of the fetus, restoration of the diaphragm muscles, bone grafts, heart valve leaflets, plantar fasciitis, osteoarthritis, spinal cord regeneration, ophthalmologic disorders, and skin repair, among others.
“Amniotic-based products are upcoming products rapidly evolving in various fields of medicine. Major progress has been made by researchers and scientists in the field of biology and engineering to advance the understanding of tissue engineering & biomaterials to enable the development of new treatments that will lessen the burden of disease.” –Senior Director, Amniotic Products Company, United States
North America Leads in terms of Adoption of Amniotic Products Market
From a regional perspective, North America holds the larger share of the amniotic products market followed by Europe. Growing research activities, adoption of amniotic membranes for major applications, growing awareness on amniotic transplants, and the presence of leading players in this region are some of the major factors driving the growth of the amniotic products market.
Competitive Landscape Analysis: Amniotic Products Market
Some of the key industry players operating in the global amniotic products market are MiMedx, Smith & Nephew, Organogenesis Inc., Integra Lifesciences, and Applied Biologics, among others.
Companies Adopting Organic Growth Strategies to Increase their Market Share
Key players operating in the global amniotic products market are adopting efficient growth strategies such as new product launches and funding to garner higher market share.
Explore Detailed Research Insights on Amniotic Products Market @ https://meditechinsights.com/amniotic-products-market/
